Group One Trading
CORT icon

Group One Trading’s Corcept Therapeutics CORT Stock Holding History

Group One Trading’s Portfolio CORT Stock Details CORT Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		– Sell
-39,186
Closed -$2.37M – 7700
2026
Q1 		$1.58M Buy
+39,186
New +$1.47M ﹤0.01% 2288
2023
Q1 		– Sell
-7,828
Closed -$172K – 7309
2022
Q4 		$159K Buy
+7,828
New +$196K ﹤0.01% 4048
2021
Q3 		– Sell
-2,764
Closed -$57.8K – 8236
2021
Q2 		$61K Buy
+2,764
New +$61.5K ﹤0.01% 6406
2020
Q2 		– Sell
-7,437
Closed -$104K – 5827
2020
Q1 		$88K Buy
+7,437
New +$92K ﹤0.01% 3387
2019
Q4 		– Sell
-20,701
Closed -$288K – 5167
2019
Q3 		$293K Buy
+20,701
New +$254K ﹤0.01% 2785
2019
Q2 		– Sell
-41,937
Closed -$467K – 5009
2019
Q1 		$492K Buy
+41,937
New +$521K 0.01% 1954
2018
Q2 		– Sell
-19,429
Closed -$338K – 5142
2018
Q1 		$320K Buy
+19,429
New +$360K ﹤0.01% 2395
2017
Q3 		– Sell
-6,926
Closed -$103K – 4867
2017
Q2 		$82K Buy
+6,926
New +$75.3K ﹤0.01% 3238
2016
Q3 		– Sell
-7,699
Closed -$44.8K – 4583
2016
Q2 		$42K Sell
7,699
-4,605
-37% -$24K ﹤0.01% 3409
2016
Q1 		$58K Buy
12,304
+6,000
+95% +$23.4K ﹤0.01% 3176
2015
Q4 		$31K Buy
6,304
+5,968
+1,776% +$26.9K ﹤0.01% 3691
2015
Q3 		$1K Sell
336
-6,300
-95% -$32K ﹤0.01% 4751
2015
Q2 		$40K Buy
6,636
+2,536
+62% +$15.5K ﹤0.01% 3673
2015
Q1 		$23K Buy
4,100
+3,400
+486% +$12.3K ﹤0.01% 3814
2014
Q4 		$2K Sell
700
-5,893
-89% -$18K ﹤0.01% 4680
2014
Q3 		$18K Sell
6,593
-16,516
-71% -$43.7K ﹤0.01% 4164
2014
Q2 		$65K Sell
23,109
-21,529
-48% -$63.5K ﹤0.01% 3357
2014
Q1 		$195K Buy
+44,638
New +$156K ﹤0.01% 2461

Other funds holding CORT

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
ISL
Ingalls & Snyder LLC New York $3.66B AUM 57.76% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $72.6B AUM 54.88% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
PA
Parallel Advisors San Francisco, California $6.56B AUM 32.24% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
AQR Capital Management
AQR Capital Management Greenwich, Connecticut $287B AUM 42.33% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

Group One Trading's CORT Position: Q2 2026 in Review

Group One Trading sold out of Corcept Therapeutics (CORT) in Q2 2026, closing a stake of 39,186 shares — an estimated $2.37M sold.

Group One Trading first reported a position in CORT in Q1 2014 and held it in 18 quarters. The position peaked at $1.58M in Q1 2026. 423 funds tracked by Wall St. Rank hold CORT as of Q2 2026.

  • Group One Trading reported no remaining Corcept Therapeutics position as of Q2 2026 after selling out during the quarter.
  • Group One Trading sold 39,186 Corcept Therapeutics shares in Q2 2026, an estimated $2.37M.
  • Group One Trading first reported a position in Corcept Therapeutics in Q1 2014 and held it in 18 quarters.
  • Group One Trading's Corcept Therapeutics position peaked at $1.58M in Q1 2026.
  • 423 funds tracked by Wall St. Rank held Corcept Therapeutics as of Q2 2026.

Based on Group One Trading's 13F filing for Q2 2026, filed 14 Aug 2026.